Anbio Biotechnology (NNNN) Stock Price

Anbio Biotechnology Price

CLOSED
3.84
​
Market closed

Revenue has compounded at 18.2% per year over the past 4 years to 8.65 M USD. Earnings per share have grown at 26.1% per year over the last 4 years. Anbio Biotechnology's net margin stands at 74.1%, up from 57.3% several years earlier.

Anbio Biotechnology stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Anbio Biotechnology business model & stock analysis

Anbio Biotechnology, headquartered in Frankfurt, Germany, operates in the Health Care sector within the Biotechnology industry. The company, with 27 employees, is engaged in manufacturing In Vitro Diagnostic Substances. Listed on 19 February 2025, it focuses on developing and producing diagnostic solutions for medical applications.

Frequently asked questions about Anbio Biotechnology

Converted at the current exchange rate, the Anbio Biotechnology share trades at 3.44 EUR (3.84 USD).

The revenue cannot currently be calculated for Anbio Biotechnology.

The profit cannot currently be calculated for Anbio Biotechnology.

The P/E ratio cannot be calculated for Anbio Biotechnology at the moment.

The P/S cannot be calculated for Anbio Biotechnology currently.

The Eulerpool Quality Score for Anbio Biotechnology is 4/10.

The ISIN of Anbio Biotechnology is KYG0367B1059. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Anbio Biotechnology is NNNN. The ticker symbol is used to trade Anbio Biotechnology shares on the stock exchange.

Fair ValueTerminal
3.69 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
320,253.48 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Currency
USD
Initial public offering
Feb 19, 2025
ISIN
KYG0367B1059
Cusip
G0367B105
Market capitalization
168.54 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
29.22
P/B Ratio
5.59
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
21.24 %
Last updated Oct 31, 2026, 5:04 PM

Anbio Biotechnology Peer Group